Cognoa

Cognoa

Hospitals and Health Care

Palo Alto, California 7,047 followers

We innovate solutions for early, equitable diagnosis and care of children with developmental concerns.

About us

Cognoa innovates solutions for child developmental health. We build breakthrough products like Canvas Dx, the first and only FDA authorized autism diagnostic for children ages 1.5 to 6 years that uses responsible AI to empower doctors to quickly, accurately, and fairly diagnose developmental risk without bias. Our digital solutions are child centric and designed to find, assess, and treat developmental concerns early, within the time windows that will yield the optimal outcomes. Our proprietary "whole child" approach to AI fuels our pipeline of diagnostic and therapeutic products for autism, speech and language, ADHD, childhood anxiety, and more. For more information, visit www.cognoa.com.

Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Palo Alto, California
Type
Privately Held
Founded
2013
Specialties
Machine Learning, Medtech, Med Device, Diagnostics, Healthtech, AI, Behavioral Health, Early Childhood Developmental Health, Early Childhood Development, Developmental Health, Mental Health, Digital Health, Digital Diagnostics, Early Intervention, Pediatrics, Pediatric Mental Health, Pediatric Behavioral Health, AI Healthcare, and Autism

Locations

Employees at Cognoa

Updates

Similar pages

Browse jobs

Funding

Cognoa 5 total rounds

Last Round

Series B

US$ 73.1M

See more info on crunchbase